PMID- 17220908 OWN - NLM STAT- MEDLINE DCOM- 20070417 LR - 20181113 IS - 0007-1188 (Print) IS - 1476-5381 (Electronic) IS - 0007-1188 (Linking) VI - 150 IP - 4 DP - 2007 Feb TI - Long-term treatment with TGFbeta1 impairs mechanotransduction in bovine aortic endothelial cells. PG - 424-33 AB - BACKGROUND AND PURPOSE: Vascular endothelial cells play a role in the physiological response to mechanical stress. Transforming growth factor beta1 (TGFbeta1) induces morphological changes in endothelial cells, and this may alter their mechanosensitive responses. The aim of this study was to examine the effects of TGFbeta1 on hypotonic stress (HTS)-induced responses in bovine aortic endothelial cells (BAECs). EXPERIMENTAL APPROACH: Cultured BAECs were treated with 3 ng ml(-1) TGFbeta1 for 24 h (24h-TGFbeta1) or 7 days (7d-TGFbeta1). Cytosolic actin fibres were stained with rhodamine-phalloidin. Intracellular Ca2+ concentration was measured using fura2. Tyrosine phosphorylation and RhoA expression were assessed by Western blotting. Expression of RhoA mRNA was assessed by real-time PCR. KEY RESULTS: BAECs developed pseudopod-like processes within 24 h and showed a fibroblast-like appearance after 7 days. HTS induced Ca2+ transients via endogenous ATP release in both control and 24h-TGFbeta1 BAECs but not in 7d-TGFbeta1 BAECs. We have previously shown that HTS-induced ATP release is mediated by sequential activation of RhoA and tyrosine kinases. The basal amount of membrane-bound RhoA was significantly lower in 7d-TGFbeta1 than in 24h-TGFbeta1 or control BAECs. HTS increased the membrane-bound RhoA to the same fractional level in 24h-TGFbeta1 and control BAECs, but its net maximal amount was significantly lower in 7d-TGFbeta1. HTS-induced downstream signals of RhoA activation, i.e. the tyrosine phosphorylation of FAK and paxillin, were markedly suppressed in 7d-TGFbeta1 BAECs. CONCLUSIONS AND IMPLICATIONS: These results indicate that long-term treatment with TGFbeta1 does not impair mechanoreception in BAECs but impairs mechanotransduction by affecting RhoA membrane translocation. FAU - Watanabe, M AU - Watanabe M AD - Department of Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. FAU - Oike, M AU - Oike M FAU - Ohta, Y AU - Ohta Y FAU - Ito, Y AU - Ito Y LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070115 PL - England TA - Br J Pharmacol JT - British journal of pharmacology JID - 7502536 RN - 0 (Actins) RN - 0 (Fluorescent Dyes) RN - 0 (Hypotonic Solutions) RN - 0 (RNA, Messenger) RN - 0 (Transforming Growth Factor beta1) RN - 42HK56048U (Tyrosine) RN - 8L70Q75FXE (Adenosine Triphosphate) RN - EC 3.6.5.2 (rhoA GTP-Binding Protein) RN - SY7Q814VUP (Calcium) RN - TSN3DL106G (Fura-2) SB - IM MH - Actins/physiology MH - Adenosine Triphosphate/metabolism/physiology MH - Animals MH - Aorta/cytology MH - Aorta, Thoracic/cytology/drug effects MH - Blotting, Western MH - Calcium/metabolism/physiology MH - Calcium Signaling/drug effects MH - Cattle MH - Cytosol/drug effects/ultrastructure MH - Endothelial Cells/*drug effects/ultrastructure MH - Fluorescent Dyes MH - Fura-2 MH - Hypotonic Solutions MH - Mechanoreceptors/*drug effects MH - Phosphorylation MH - Physical Stimulation MH - RNA, Messenger/biosynthesis MH - Reverse Transcriptase Polymerase Chain Reaction MH - Signal Transduction/*drug effects MH - Transforming Growth Factor beta1/*pharmacology MH - Tyrosine/metabolism MH - rhoA GTP-Binding Protein/biosynthesis PMC - PMC2189726 EDAT- 2007/01/16 09:00 MHDA- 2007/04/18 09:00 PMCR- 2008/02/01 CRDT- 2007/01/16 09:00 PHST- 2007/01/16 09:00 [pubmed] PHST- 2007/04/18 09:00 [medline] PHST- 2007/01/16 09:00 [entrez] PHST- 2008/02/01 00:00 [pmc-release] AID - 0707123 [pii] AID - 10.1038/sj.bjp.0707123 [doi] PST - ppublish SO - Br J Pharmacol. 2007 Feb;150(4):424-33. doi: 10.1038/sj.bjp.0707123. Epub 2007 Jan 15.